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ABSTRACT 
BACKGROUND: Women are twice as likely as men to suffer from stress-related psychiatric 
disorders. However, the biological basis of these sex differences is poorly understood.  Orexins 
are altered in anxious and depressed patients. Using a rat model of repeated stress, we asked 
whether orexins contribute to sex differences in outcomes relevant to stress-related psychiatric 
diseases.  
METHODS: Behavioral, neural, and endocrinal habituation to repeated restraint stress and 
subsequent cognitive flexibility was examined in adult male and female rats. In parallel, orexin 
expression and activation was determined in both sexes, and chromatin immunoprecipitation 
was used to determine transcription factors acting at the orexin promoter.  DREADDs (Designer 
Receptors Exclusively Activated by Designer Drugs) were used to inhibit orexin activation 
throughout repeated restraint to determine if the stress related impairments in females could be 
reduced.   
RESULTS: Female rats exhibited impaired habituation to repeated restraint with subsequent 
deficits in cognitive flexibility compared to male rats.  Increased orexin expression and activation 
was observed in females compared to males. The higher expression of orexin mRNA in females 
was due to actions of glucocorticoid receptors on the orexin promoter, as determined by 
chromatin immunoprecipitation. Finally, inhibition of orexins using DREADDs in 
females throughout repeated restraint abolished their heightened HPA responsivity and reduced 
stress-induced cognitive impairments. 
CONCLUSIONS:  The results demonstrate that orexins mediate the impairments in adaptations 
to repeated stress and in subsequent cognitive flexibility exhibited by female rats and provide 
evidence for a broader role for orexins in mediating functions relevant to stress related 
psychiatric diseases. 
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Introduction 
Stress-related psychiatric disorders are twice as common in women, however, the neurobiology 
underlying these sex differences is not fully understood (1–3). An important adaptation to 
repeated stress called habituation, is defined as decreased behavioral, hypothalamic pituitary 
adrenal (HPA) and autonomic responses to moderately intense stressors (4).  Habituation to 
repeated stress, including the HPA response, is disrupted in stress-related illnesses such as 
post-traumatic stress disorder (PTSD) and panic disorder (5). The HPA axis integrates the 
response to a stressor at the paraventricular hypothalamus (PVN), which causes downstream 
release of ACTH from the anterior pituitary, and ultimately glucocorticoid release from the 
adrenal glands. Corticosterone, the primary glucocorticoid in rodents, binds to glucocorticoid 
and/or mineralocorticoid receptors (GR and MR, respectively) to exert its effects in the periphery 
and in the brain. Stressful life events can also impair cognitive function, including cognitive 
flexibility (6), which precipitates or exacerbates many psychiatric disorders (7). Patients with 
disorders such as panic disorder and PTSD exhibit altered concentrations of the hypothalamic 
peptides orexins in cerebrospinal fluid (5, 8, 9). Orexins regulate neuroendocrine and behavioral 
responses that are affected in stress-related illness including disruptions in the HPA axis, 
cognitive flexibility, arousal, food intake, and emotional memory (5, 10, 11). Sex differences in 
orexin precursor prepro-orexin mRNA have been reported (12), but neither the mechanisms 
underlying this sex difference nor the functional consequences of this disparity is understood. 
 To address these gaps in knowledge, we conducted a detailed examination of sex 
differences in the HPA response to repeated stress and in subsequent cognitive flexibility in an 
operant strategy shifting test (13). We then determined the role of orexins in mediating these 
effects of stress. The results indicate that elevated orexins in female rats are responsible for the 
heightened HPA responses to repeated stress and the stress-induced impairments in cognitive 
flexibility. Together, the results suggest a novel role for orexins in mediating sex differences in 
functions that are altered in stress-related psychiatric disorders.   
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Methods and Materials 
Animals: Male and female Sprague-Dawley rats between 65-75 days of age were obtained from 
Charles River Laboratories (Wilmington, MA, USA).  Rats were singly housed and had food and 
water available ad libitum, under 12-h light/dark cycle. Animals acclimated to the housing and 
lighting conditions for 5 days prior to any surgical or stress protocols. The Institutional Animal 
Care and Use Committee of The Children’s Hospital of Philadelphia (CHOP) Research Institute 
approved all experimental procedures. 
 
Experiment 1: Habituation to Repeated Restraint: Behavioral, Neural, and Endocrine Measures 
Two cohorts of animals were used in these experiments (n = 48 animals, 8/treatment group: 
See Figure 1A for treatment groups and experimental paradigm). Animals were restrained in 
Plexiglas restrainers differently sized for male or female rats for 30min/day for 5 consecutive 
days. As orexins exhibit a circadian rhythm (14), animals were restrained within 2h after lights 
on so that levels of orexin remained consistent. Noldus software was used to quantify time 
spent struggling from videos of the first 10 min of restraint, as previously described (4, 15). 
Blood samples were taken on Day 1 and Day 5 of restraint for ACTH and corticosterone as 
previously described (16).  
 To assess activation in the parvocellular division of the PVN (pPVN) after restraint, rats 
were rapidly decapitated 30 minutes following restraint on day 5 and brains were flash frozen in 
2-methyl butane. Sections through the pPVN (-1.72 mm to -1.92 mm from bregma) were fixed in 
4% paraformaldehyde, immunostained for c-Fos (1:1250, sc-52; Santa Cruz Biotechnology, 
Santa Cruz, CA) , and analyzed in NIH Image J by two investigators blind to  treatment 
conditions.  
 
 
Grafe, L. 
 4 
Experiment 2: Effects of Repeated Restraint on Cognitive Flexibility  
Three cohorts of animals were used in this experiment (n= 48 animals, 12/ treatment group: 
Control Males, Control Females, 5 Day Restrained Males, or 5 Day Restrained Females). Male 
and female rats were either left in their home cages or restrained for five days. On the 6th day, an 
operant set shifting protocol was performed and analyzed as in Snyder et al ((13); See SI and 
Figure 2A).  
 
Experiment 3: Orexin Expression and Activation in Male and Female Rats  
Brains of control animals from Experiment 1 were used to assess prepro-orexin mRNA (as 
described in (17, 18)) and brains from control, 1 day, or 5 day restrained rats were used to 
measure activation of orexin neurons. A separate cohort of rats was used for cerebrospinal fluid 
collection (12/group: Control Males and Control Females). Activation of orexinA-immunoreactive 
neurons was assessed by a dual stain for c-Fos (as described above) and orexinA (1:50, sc-8070; 
Santa Cruz Biotechnology, Santa Cruz CA), followed by biotinylated Horse Anti-Goat antibody 
(1:500, BA-9500; Vector Laboratories, Burlingame, CA) and a Nova Red reaction (SK-4800, 
Vector Laboratories, Burlingame, CA). Dual labeled cells (Fos nuclear black stain and orexinA 
cytoplasmic red stain) were counted by observers blind to experimental conditions. 
 Cerebrospinal fluid was collected from the cisterna magna of anesthetized rats and 
orexinA concentrations were assayed by radioimmunoassay (Phoenix Pharmaceuticals; 
Burlingame, CA). The minimum levels of detection for orexinA was 80 pg/ml.  Intra-and 
interassay variability was 5-7% and 12-15%. 
 
Experiment 4: Examining the Glucocorticoid Receptor (GR) regulation of prepro-orexin mRNA 
Sections of the LH from control males and females in Experiment 1 were used to examine GR 
expression in orexin neurons. Immunofluorescence was performed with primary antibodies for 
Orexin A and GR (1:50, SC-1004, Santa Cruz Biotechnology; Santa Cruz, CA), followed by 
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AlexaFluor488 Donkey anti-goat and AlexaFluor647 Donkey anti-rabbit secondary antibodies 
(1:200, A-11055 and A-31573; Life Technologies, Carlsbad, CA). A colocalization plugin was 
used in ImageJ to determine percent orexin neurons that express GR. 
To examine potential transcription factors that act on the prepro-orexin promoter, the 
sequence for prepro-orexin was entered into the ALGGEN PROMO virtual laboratory (See SI), 
which identified the GR (α and β). Chromatin immunoprecipitation (ChIP) was performed for GR 
in the LH of control male and female rats (8/treatment group) using a standard kit (Catalog # 17-
295, EMD Millipore). qPCR was performed at specific primer set locations along the prepro-
orexin promoter, where GR was predicted to bind (See SI).  
 Two cohorts of female rats were used to test whether GR regulates prepro-orexin 
expression in females (8/treatment group: Females injected with scrambled siRNA or Females 
injected with siRNA directed at the GR). Oligodeoxynucleotides (ODNs) (Eurofins MWG 
Operon; Huntsville, AL) directed at the GR were used to knock down its expression in the LH as 
previously described (19). In order to confirm knockdown of the GR by siRNA, slides were 
stained immunofluorescently for GR and orexinA. Additionally, LH punches from another cohort 
of control or siRNA treated female rats were collected 24 hours after the third day of ODN 
injections (6/group). QPCR on LH punches was performed using a Sybr Green Master Mix 
(Thermo Fisher Scientific; Pittsburgh, PA) and primers for GR (forward: AGG GGA GGG GGA 
GCG TAA TGG reverse: CCT CTG CTG CTT GGA ATC TGC) and GAPDH (forward: GAC ATG 
CCG CCT GGA GAA AC reverse: AGC CCA GGA TGC CCT TTA GT).  
 
Experiment 5: Inhibiting Orexin via Designer Receptors Exclusively Activated by Designer Drugs 
(DREADDs) throughout Repeated Restraint  
Four cohorts of animals were used in these studies (n = 64 animals, 8/group: Females injected 
with Vehicle or Clozapine N-Oxide (CNO). Both groups had the DREADDs virus expressed in the 
LH (see SI for more construct information).  Half of the animals were analyzed for pPVN and 
Grafe, L. 
 6 
orexin activation after the fifth restraint and half continued on to the strategy shifting test.  
 Female rats received injections of vehicle (saline and 8% DMSO) or CNO (Sigma-
Aldrich; St Louis, MO 2 mg/kg ip) 60 minutes prior to the start of the 30-minute restraint for 5 
consecutive days. This timing was chosen because CNO promotes behavioral effects in the rat 
within 30 minutes and effects last up to 4 hours (20, 21). Blood was collected on day 1 and day 
5 of restraint and assayed for ACTH and corticosterone. Some females were sacrificed after 5 
days of restraint to assess c-Fos in the pPVN and in orexin neurons as described above, while 
others continued to the strategy shifting test to be assessed for cognitive flexibility, as described 
above. 
 A new cohort of female rats (n 16, 8/group) underwent 5 consecutive days of 30-minute 
restraint with SB334867 (an orexin 1 receptor antagonist) administered 30 min prior to daily 
restraint.  Tail blood for these rats were collected on day 1 and 5 of restraint. 
 
Statistical Analysis: Two-way ANOVAs examined Sex and Stress variables for habituation and 
strategy shifting data. T-tests compared control males and females for orexin 
expression/activation and ChIP data. For DREADDs data: t-tests compared vehicle- and CNO-
treated stressed females for pPVN activation, orexin activation, and basal plasma corticosterone; 
two-way ANOVAs were used to examine ACTH and corticosterone data; one-way AVOVA were 
used to analyze strategy shifting data. T-tests compared control and GR SiRNA treated rats for 
QPCR and prepro-orexin analysis. Statistical analysis was conducted with GraphPad Prism 
(GraphPad Software, La Jolla, CA, USA). 
 
Results 
Females exhibit impaired habituation to repeated stress  
 Female rats spent significantly more time struggling in response to the 1st and 5th restraint 
compared with males (Figure 1A). Moreover, on day 5, time spent struggling in males was 
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reduced to 46% of its value on day 1, but the reduction in females was only to 69% of its value 
on day 1, indicating reduced behavioral habituation to repeated restraint in females. 
 cFos activation in the pPVN was significantly increased by acute restraint in males and 
reduced by day 5, comparable to that of control males (Figure 1B). In contrast, in females, pPVN 
activation was significantly increased acutely, and remained elevated on day 5 of restraint 
compared to control females, indicating continued activation of the pPVN with repeated restraint 
in female rats. Consistent with these results, integrated plasma ACTH levels were significantly 
decreased in males but not females by day 5 of restraint compared with day 1 (Figure 1C). The 
same sex difference was observed in integrated plasma corticosterone concentrations. 
Additionally, females displayed significantly higher plasma corticosterone concentrations at both 
day 1 and 5 compared with males. Interestingly, females but not males had significantly higher 
basal corticosterone concentrations on day 5 of restraint compared with their respective day 1 of 
restraint. These results indicate that behavioral, neural and neuroendocrine habituation to 
repeated stress is diminished in female rats compared to male rats and that female rats exhibited 
heightened baseline glucocorticoid release after repeated restraint. 
 
Female rats exhibit impaired cognitive flexibility after repeated stress  
 Control and repeatedly restrained males and females trained in an operant strategy 
shifting test (see Figure 2A), followed by a test day, which consisted of three tasks: Side 
Discrimination, Side Reversal, and Light Discrimination. Stressed males required significantly 
fewer trials than control males to complete the side reversal task (Figure 2B). In contrast, stressed 
females required significantly more trials than control females to complete the side reversal task. 
Thus, stress improved performance in males but impaired performance in females in the side 
reversal task. In the light discrimination task, stress increased the number of trials to criterion in 
females, thereby impairing performance in this task.   
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 Stressed males made fewer errors than control males in the side reversal task, consistent 
with their fewer trials to criterion (Figure 2C). Moreover, stressed females made significantly more 
errors than control females in both the side reversal and light discrimination tasks, consistent with 
their impaired performance in trials to criterion for both tasks. Total errors were further categorized 
into perseverative or regressive errors (Figure 2D, for more detail, see SI and (13)). In the side 
reversal task, stressed males made less perseverative errors compared with control males. In 
contrast, stressed females made more perseverative errors than control females in both the side 
reversal and light discrimination tasks. There were no differences between the treatment groups 
in the number of regressive errors in either task. Stressed males took less time to complete the 
side reversal task than control males, while stressed females took significantly more time to 
complete the side reversal task (Figure 2E). In addition, stressed females made a higher 
percentage of omissions compared with control females, contributing to this longer time to 
complete the task. In summary, stressed females made more omissions and perseverative errors 
in the side reversal task, contributing to their impaired performance in this task. 
 
Female rats exhibit elevated baseline orexin expression and activation compared to male rats 
 Orexin system function was assessed at several levels.  First, significantly higher prepro-
orexin mRNA was observed in control females compared with control males (Figure 3A) as 
assessed by in situ hybridization. Next, control females exhibited significantly more activation of 
orexin neurons compared with control males as assessed by dual labeling for orexinA and cFos 
(Figure 3B). While day 1 of restraint induced significant activation of orexin neurons, orexin 
activation returned to its respective baseline by day 5 of restraint in both sexes. However, orexin 
neural activation in females was still significantly higher than males after repeated restraint. 
Finally, concentrations of orexinA were significantly higher in the cerebrospinal fluid of females 
Grafe, L. 
 9 
compared to males (Figure 3C). In summary, females displayed higher levels of baseline orexin 
expression and activation compared with control males. 
 
Glucocorticoid receptors promote elevations of prepro-orexin mRNA in females  
 We next explored the mechanism by which orexins are increased in females compared 
with males. We examined candidate transcription factors that may bind to the orexin promoter 
and upregulate prepro-orexin mRNA in females, one of which was the GR, which is known to be 
expressed in orexin neurons ((22) and see Figure 4A). Chromatin immunoprecipitation revealed 
that GR bound to several sites on the orexin promoter (Figure 4B) with higher enrichment of GR 
in control females compared with males in the HCRT1, HCRT5, and HCRT6 primer sets. We also 
showed amplification of the period 1 promoter, a positive control of which GR is known to bind, 
based on previous literature (23) and no amplification at the GAPDH promoter, a negative control. 
While these results indicated that the GR is enriched at the orexin promoter in females, they did 
not determine whether this enrichment leads to the upregulation of prepro-orexin in females. To 
test this, GR siRNA was administered into the LH in female rats. There was stable knockdown of 
GR in orexin neurons (Figure 4C) confirming the efficacy of the GR siRNA.  Critically, this GR 
knockdown reduced prepro-orexin mRNA in females compared to scrambled control (Figure 4D), 
demonstrating that GR directly acts at the orexin promoter to upregulate orexin expression in 
female rats. 
 
Orexins contribute to HPA activity and cognitive impairment after repeated restraint in females 
 The previous results lead to the hypothesis that higher orexin system activity in females 
produces their reduced habituation and impaired cognitive flexibility. To test this hypothesis, 
orexin system activity was reduced in females using two different approaches. First, an inhibitory 
DREADDs construct targeted to orexins (referred to as hM4D-orexins) was developed to inhibit 
orexin cells in females throughout repeated restraint (see Figure 5A). Inhibition of hM4D-orexins 
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transfected neurons by Clozapine N-Oxide (CNO) administration prior to each restraint 
significantly reduced neural activity in both orexin neurons and in pPVN cells in stressed females 
by day 5 of restraint (Figure 5B and C), decreased plasma ACTH concentrations by day 5 of 
restraint compared with day 1 (Figure 5D) and eliminated the heightened basal plasma 
corticosterone concentrations in stressed females by day 5 of restraint (Figure 5E). This 
augmented basal corticosterone on day 5 was also abolished through use of a second approach 
to reduce orexin activity, ip administration of the orexin 1 receptor antagonist SB334867 prior to 
each daily restraint. To summarize, inhibiting orexin action during repeated restraint was sufficient 
to induce habituation to repeated restraint in females and to lower their heightened baseline 
glucocorticoid release. Moreover, inhibiting orexin neurons throughout restraint reduced the trials 
to criterion, time to criterion, and number of omissions in the side reversal task in stressed females 
(Figure 5F and 5G). Thus, inhibition of orexins throughout repeated restraint ultimately improved 
cognitive flexibility in females. 
 
Discussion 
 Inability to adapt to repeated stress, including an impaired habituation to familiar non-life-
threatening stressors and disruptions in cognitive functions are common in illnesses such as 
depression and PTSD (5, 7). For the first time, a detailed examination of sex differences in the 
ability to habituate to stress and in subsequent cognitive flexibility revealed that female rats 
exhibited reduced habituation and enhanced baseline glucocorticoid concentrations after 5 days 
of restraint, a moderately intense and primarily cognitive stressor (24). Furthermore, female rats 
exhibited disruptions in cognitive flexibility after stress whereas cognitive flexibility improved in 
male rats after stress. To determine the mechanisms that contribute to these sex differences, 
we examined the neuropeptides orexins, since orexins have been shown to contribute to both 
the HPA response and cognitive function (10, 11, 25, 26). We discovered that nonstressed 
female rats had higher prepro-orexin expression, activation of orexin neurons, and higher orexin 
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levels in the cerebrospinal fluid compared with male rats. We then determined that GR acts on 
the prepro-orexin promoter to increase prepro-orexin mRNA. Using both inhibitory DREADDs 
specifically targeted to orexin neurons and pharmacological approaches to inhibit orexin 
receptors, we determined that the enhanced orexins produce both the impaired habituation to 
restraint and subsequent cognitive deficits in females. These results suggest that orexins are 
important mediators of sex differences in the response to repeated stress and subsequent 
cognitive function, providing important insights in both the etiology and treatment of psychiatric 
diseases. 
 
Sex differences in habituation to stress  
 Though it is well established that female rats have a higher HPA response to acute 
stressors than male rats (27), fewer studies have examined sex differences in adaptations to 
repeated stress such as habituation. Through behavioral, neuronal, and endocrine measures, the 
results suggest that females do not habituate as fully as males to 5 consecutive days of 30-minute 
restraint.  This does not preclude the possibility that females may habituate similarly to males with 
further exposure to the same stressor.  While other studies from our lab have found that females 
still do not display habituation at 8 consecutive days of 30-min restraint (28), a recent study found 
that 10 days of 30-min restraint produced habituation in both sexes (29).  However, by examining 
this point in time when sex differences in the stress response do occur, we are able to study the 
neurobiology underlying the increased sensitivity to stress displayed by females, shedding light 
on gender biased stress-related illness. 
   
Sex differences in cognitive function after stress      
 In humans, stressful life events impair cognitive function, precipitating or exacerbating 
many psychiatric disorders (30). Aspects of executive functioning in humans can be assessed 
using the Wisconsin Card Sorting Task, a demonstration of cognitive flexibility (31). Stress impairs 
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cognitive flexibility using analogous tests in rodents including the attentional set shifting task and 
the operant strategy shifting task used here (13).  However, there has been limited research 
directly examining sex differences in these paradigms (13, 32). Our results are the first to 
demonstrate that repeated stress leads to sex-specific deficits in cognitive flexibility in rats.  
Females performed worse on both the side reversal and light discrimination tasks after stress, as 
indicated by an increased number of trials to criterion, perseverative errors, and omissions.  In 
contrast, repeated restraint improved male performance in the side reversal task. Perseveration 
is observed in stress-related psychiatric disorders such as PTSD, and impairs the ability of one 
to learn a new set of rules, ultimately impairing working memory (7). Omissions in attention tasks 
have also been noted in patients with PTSD, indicating slower cortical processing (7).  As 
cognitive inflexibility is a prominent phenotype in stress-related psychiatric disorders, the results 
suggest that females may be more vulnerable to this type of cognitive impairment after repeated 
stress compared with males. 
 
Sex differences in orexin expression are produced by actions of GRs    
As orexins are known to contribute to both the stress response and cognitive function, it was 
possible that these neuropeptides could explain the sex differences we observed.  Sex differences 
in prepro-orexin mRNA have been noted in Wistar Rats (12).  We replicated and extended these 
initial findings, demonstrating that female Sprague Dawley rats not only exhibit higher baseline 
levels of prepro-orexin mRNA, but additionally display higher activation of orexin neurons and 
increased orexinA concentrations in the cerebrospinal fluid compared with male rats. While other 
studies indicate that female rats display higher prepro-orexin mRNA during proestrus (33, 34), a 
study that ovariectomized females showed no reduction in prepro-orexin mRNA, further 
suggesting that this sex difference is not mediated by female gonadal hormones (35). However, 
both the paucity and equivocal nature of this literature leaves the contribution of female gonadal 
hormones in regulating prepro-orexin expression unclear.  
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We next examined possible mechanisms responsible for higher orexin expression and 
activation in females. We hypothesized that transcription factors more prevalent or active in 
females may bind to the orexin promoter and cause upregulation of orexin expression.  A 
transcription factor binding prediction program revealed that the consensus sequence for the 
GR may bind to the orexin promoter. Using chromatin immunoprecipitation, we found GR to be 
more highly enriched at the orexin promoter in females compared with males. GR expression 
was inhibited in the LH of female rats using siRNA and this inhibition did indeed produce a 
decrease in prepro-orexin expression suggesting that GR is responsible for the upregulation of 
prepro-orexin in females. These data suggest that the GRs directly on the orexin promoter 
increase prepro-orexin expression in females, providing a novel regulatory mechanism for the 
control of orexin system activity.  
Our studies focused on baseline changes in orexin regulation of habituation and 
cognitive function and did not characterize relationship between orexins and GRs in stressed 
animals. It is possible that this relationship is different than in control animals. The activation of 
the GR changes with stress which could obscure our understanding of the relationship between 
glucocorticoids and orexins under basal conditions, as investigated here. Future studies are 
necessary to delineate the relationship between orexins and glucocorticoids throughout 
repeated stress.   
 
Inhibiting orexins rescues habituation to stress and cognitive flexibility in females  
 We next examined the role of orexins in regulating the sex differences that we observed 
in habituation to stress and subsequent cognitive function.  We found that inhibiting orexin 
neurons prior to each restraint using hM4D-orexins reduced pPVN activation, integrated ACTH 
levels and basal corticosterone concentrations at day 5 of restraint.  This reduction of basal 
corticosterone levels by day 5 of restraint was also induced by pharmacological means through 
administration of the orexin 1 receptor antagonist SB334867, indicating that the orexin 1 receptor 
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is responsible for higher basal corticosterone in females after repeated restraint. Thus, these data 
suggest that the relationship between glucocorticoids and orexins is bidirectional: not only can 
GR increase central orexin expression, but decreasing orexin action lowers basal glucocorticoid 
levels. Further, these results suggest a novel mechanism for regulation of basal glucocorticoid 
release. This is important because basal glucocorticoids are higher in patients with depression 
(36). Thus, if orexins contribute to an increase in basal glucocorticoids, inhibiting these 
neuropeptides may aid in treatment of certain aspects of this neuropsychiatric disorder. By 
extension, understanding how orexins regulate basal glucocorticoids may also inform aspects of 
disorders where basal glucocorticoids are low, such as in PTSD (37). 
 We then examined whether inhibiting orexins throughout repeated restraint impacted 
subsequent cognitive flexibility. We found that inhibiting orexin neurons prior to each restraint with 
hM4D-orexins reduced subsequent cognitive impairments in strategy shifting in stressed females. 
Specifically, inhibiting orexin neurons markedly reduced the number of trials to criterion, the 
number of omissions, and the time it took to complete the side reversal task. Overall, these results 
indicate that orexins actions during repeated stress are important for the subsequent impairments 
in strategy shifting in female rats.  
 
Conclusions and Future Directions  
 The present studies demonstrated that elevated expression and activation of orexin 
neurons in female rats, due in part to GR actions at the prepro-orexin promoter, underlies their 
inability to habituate to repeated stress. Furthermore, orexins are involved in behavioral 
consequences of stress, contributing significantly to stress-induced impairment in cognitive 
flexibility in females. Together, these results demonstrate that orexins are novel regulators of sex 
differences in neural, behavioral and neuroendocrine adaptations to repeated stress and in the 
cognitive consequences of repeated stress exposure. The results suggest that orexins could be 
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important in the etiology of those stress-related psychiatric disorders that present differently in 
men and women.  
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Figure Legends 
 
Figure 1.  Habituation is diminished in female compared to male rats.  
Panel A. Top: Repeated restraint paradigm. Bottom: Time spent struggling while in the restrainer 
is quantified. Males reduce cumulative duration of movement to 46% of day 1 by day 5, whereas 
females only reduce to 69% of day 1 by day 5. Females display significantly higher struggle 
behavior on both day 1 and 5 compared with males. (Sex effect, F(1,24) = 36.7, p<0.0001; Stress 
effect, F(1,24) = 17.5, p<0.001; two-way ANOVA followed by Tukey’s t-test; n = 8/group) Panel 
B. pPVN activation in control, 1 day restrained, and 5 days repeatedly restrained male and female 
rats. Representative images of cFos staining, with dotted lines outlining the pPVN. While day 1 of 
restraint induces significant cFos staining in both males and females, males have significantly 
lower cFos activation by day 5, whereas pPVN neurons remain activated in females on day 5. 
(Stress effect, F(2,28) = 7.1, p<0.01; Interaction trend, F(2,28) = 3.1, p = 0.06; two-way ANOVA 
followed by Tukey’s t-test; n = 8/group) Panel C. Integrated plasma ACTH and corticosterone on 
day 1 and 5 of restraint in male and female rats. Both plasma ACTH and corticosterone decrease 
by day 5 compared with day 1 of restraint in males, but not in females. Regardless of stress, 
plasma corticosterone levels are significantly higher in females compared with males.  (ACTH: 
Stress effect, F(1,17) = 5.9, p<0.05; Cort: Sex effect, F(1,18) = 20.0, p<0.001; two-way ANOVA 
followed by Tukey’s t-test). Basal corticosterone (0 minute time point) is significantly higher in 
females on day 1 of restraint compared with males on day 1. Moreover, females display higher 
basal corticosterone on day 5 of restraint compared with day 1, whereas males do not (Sex effect, 
F(1,39) = 25.6, p<0.001; Stress effect, F(1,39) = 9.2, p<0.01; Interaction effect, F(1,39) = 11.5, 
p<0.01; two-way ANOVA followed by Tukey’s t-test; n = 8/group). *P<0.05, **P<0.01, ***P<0.001 
 
 
Figure 2.  Repeated stress impairs cognitive flexibility and cortical activation in females. 
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Panel A. Schematic illustrating the operant set shifting paradigm training days. § Adapted from 
Behavioural Brain Research, Volume 190 (Issue 1). Floresco SB, Block AE, and Tse M. 
“Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal 
learning, using a novel, automated procedure”, p85-96, 2008, with permission from Elsevier. 
Panel B. Trials to criterion for each task on test day.  In the side reversal task, stress improved 
performance in males but impaired performance in females (Stress effect, F(1,23) = 6.0, p<0.05; 
Interaction effect, F(1,23) = 31.7, p<0.0001; two-way ANOVA followed by Tukey’s t-test). In the 
light discrimination task, stress impaired performance in females while it did not affect males 
(Stress trend, (F(1,25) = 2.8, p = 0.1); two-way ANOVA followed by Tukey’s t-test; n = 12/group). 
Panel C. Number of errors for each task on test day. Stress decreases errors made in males but 
increases errors made in females in both the side reversal and light discrimination tasks (Side 
Reversal: Interaction effect, F(1,28) = 6.5, p<0.05; Light Discrimination: Interaction trend, F (1,28) 
= 3.4, p = 0.08; two-way ANOVA followed by Tukey’s t-test). Panel D. Perseverative and 
regressive error characterization. Stress decreases perseverative errors made in males but 
increases perseverative errors made in females in both the side reversal and light discrimination 
tasks (Side Reversal: Interaction effect, F (1,26) = 6.7, p<0.05; Light Discrimination: Stress effect, 
(F (1,26) = 5.3, p<0.05; two-way ANOVA followed by Tukey’s t-test). Panel E. Time to criterion 
and % trials omitted in the side reversal task. Stress decreases the time it takes males but 
increases the time required by females to complete the task. This may be explained by increased 
number of omissions exhibited by females after stress (Time: Interaction effect, F (1,28) = 7.8, 
p<0.01; two-way ANOVA followed by Tukey’s t-test). #P≤0.10, *P<0.05, ****P<0.0001 
 
 
 
Figure 3. Females have higher orexin expression and activation than males.  
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Panel A. Representative photomicrographs of in situ radiolabeling for prepro-orexin mRNA in the 
LH in control male and female rats.  Dark black grains indicate prepro-orexin expression. Control 
females express significantly more prepro-orexin mRNA than control males (p<0.05; t-test; n = 
8/group).  Panel B. Orexin neural activation in control, 1 day restrained, and 5 days repeatedly 
restrained male and female rats. Representative 10x images of an orexin/cFos dual stain in the 
LH in control male and female rats. ƒ denotes the fornix. The box with dashed lines in the 
representative control female image is displayed at 40x. Orexin neurons can be visualized by red 
cytoplasmic stains (NovaRed reaction, Δ symbol) and cFos can be visualized with black nuclear 
stains (Nickel DAB reaction). The arrow denotes a dual cFos and orexin labeled cell. Control 
females have significantly more activated orexin neurons than males. While day 1 of restraint 
induces significant activation of orexin neurons, orexin activation returns to its respective baseline 
by day 5 of restraint in both sexes. However, orexin neural activation in females is still significantly 
higher than males after repeated restraint. (Stress effect, F(2,97) = 36.5, p<0.0001; Sex effect, 
F(1,97) = 21.0, p<0.0001; Interaction effect, F(2,97) =8.7, p<0.001; two-way ANOVA followed by 
Tukey’s t-test; n = 8/group).  Panel C. Cerebrospinal fluid was collected from the cisterna magna 
and assayed for Orexin A. Females have significantly higher levels of Orexin A in the 
cerebrospinal fluid than males (p<0.05; t-test; n = 12/group). *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001 
 
Figure 4. GR is highly enriched at the orexin promoter in females compared to males. 
Panel A. A representative image of dual staining for both orexin (green, Δ symbol) and GR (red, 
arrow symbol) reveals that most orexin neurons express GR (colabeling in yellow). Specifically, 
colocalization analysis revealed that roughly 80% of orexin neurons express GR. Panel B. ChIP 
and qPCR quantified GR bound to the orexin promoter in control male and female rats.  At HCRT 
primer set 1, 5, and 6, control females were more highly enriched with the GR compared with 
control males (Primer set 1: p = 0.10; Primer Set 5: p = 0.10; Primer Set 6: p<0.05; t-test; n = 
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8/group). Panel C. Representative images of dual stain for orexin neurons and GR in control 
females (left) and females injected with siRNA directed against the GR (right). GR siRNA reduced 
visible GR staining in the LH. Additionally, GR siRNA significantly reduced GR expression in the 
LH as measured by qPCR (p<0.001; t-test; n = 6/group). Panel D. In situ radiolabeling of prepro-
orexin mRNA in control females and females injected with siRNA directed against the GR. 
Representative images of prepro-orexin expression (top) and quantification of the dark black 
grains (bottom).  siRNA directed against the GR injected into the LH decreases prepro-orexin 
mRNA expression in females compared with controls (p<0.05; t-test; n = 8/group). #P≤0.10, 
*P<0.05, ***P<0.001 
 
Figure 5.  Inhibiting orexin neurons throughout repeated restraint promotes habituation 
and reduces baseline HPA activity and subsequent cognitive impairment in female rats.  
Panel A. Representative images displaying viral expression of DREADDs in the LH at 4 weeks. 
A composite image displaying the spread of viral expression along the LH is depicted using rat 
brain atlas images (Paxinos and Watson, 1998). Each red dot represents a cell expressing the 
viral tag. A timeline of the experimental paradigm is pictured below. Panel B. Representative 
images of dual cfos/orexin staining in the LH in repeatedly restrained female rats.  CNO treated 
females (orexins inhibited prior to each restraint) exhibited significantly less activation in orexin 
neurons compared with vehicle treated females (p<0.05, t-test, n = 8/group). Panel C. 
Representative images of cFos staining in the pPVN in repeatedly restrained female rats. CNO 
treated females (orexins inhibited prior to each restraint) exhibited significantly less activation in 
the pPVN compared with vehicle treated females. (p<0.05; t-test; n = 8/group). Panel D. 
Integrated plasma ACTH and corticosterone responses to Day 1 and Day 5 of restraint. CNO 
treated females exhibited significantly lower plasma ACTH by day 5 of restraint (Stress effect, 
F(1,13) = 5.3, p<0.05; two-way ANOVA followed by Tukey’s t-test). Panel E. Basal plasma 
corticosterone levels on day 5 in repeatedly restrained females. CNO treated females exhibited 
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significantly lower basal plasma corticosterone levels on day 5 of restraint (p<0.01; t-test).  
Treatment with orexin receptor antagonist SB334867 also significantly reduced basal 
corticosterone levels by day 5 of restraint (p<0.05; t-test; n = 8/group). Panel F. Trials to criterion 
in repeatedly restrained females. CNO treated females exhibited a reduced number of trials to 
criterion in the side reversal task. (p<0.05; t-test; n = 8/group). Panel G. Time to criterion and 
percent trials omitted in the side reversal task in repeatedly restrained females. CNO treated 
females exhibited both reduced time and reduced percent trials omitted in the side reversal task 
(Time: p=0.10, Omissions: p<0.01; t-test). #P≤0.10, *P<0.05, **P<0.01 
 
